Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
22.65
+0.08 (0.35%)
Apr 25, 2025, 11:32 AM EDT - Market open
Claritev Revenue
In the year 2024, Claritev had annual revenue of $930.62M, down -3.21%. Claritev had revenue of $232.15M in the quarter ending December 31, 2024, a decrease of -4.91%.
Revenue (ttm)
$930.62M
Revenue Growth
-3.21%
P/S Ratio
0.39
Revenue / Employee
$344,676
Employees
2,700
Market Cap
366.89M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CTEV News
- 4 hours ago - Claritev and Burjeel Holdings Partner to Advance Revenue Integrity Solutions in the MENA Region - Business Wire
- 8 days ago - Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy - Business Wire
- 10 days ago - Claritev's Ceres® Named “Data Solution of the Year for Insurance” in 2025 Data Breakthrough Awards Program - Business Wire
- 15 days ago - Claritev Corporation Announces First Quarter 2025 Earnings Conference Call - Business Wire
- 15 days ago - Claritev Announces Sponsorship Agreement with Professional Golfer Neal Shipley - Business Wire